Table 3.
Applied therapies with corresponding recurrence/persistence rates.
| Therapies | No Recurrence (%) | Recurrence (%) | Persistence (%) | Total |
|---|---|---|---|---|
| Monotherapy | 66 (54,5%) | 28 (23,1%) | 27 (22,3%) | 121 |
| Combined therapy | 52 (62,7%) | 23 (27,7%) | 8 (9,6%) | 83 |
| Excision | 16 (64%) | 8 (32%) | 1 (4%) | 25 |
| Cryotherapy | 11 (57,9%) | 5 (26,3%) | 3 (15,8%) | 19 |
| Sporadic Corticosteroids | 22 (53,7%) | 5 (12,2%) | 14 (34,1%) | 41 |
| Protocolled Corticosteroids | 11 (44%) | 10 (40%) | 4 (16%) | 25 |
| Silicone | 6 (54,5%) | 0 (0%) | 5 (45,5%) | 11 |
| Combined without cryotherapy | 47 (66,2%) | 18 (25,4%) | 6 (8,5%) | 71 |
| Combined with Cryotherapy | 5 (41,7%) | 5 (41,2%) | 2 (16,7%) | 12 |
| Total | 118 (57,8%) | 51 (25,0%) | 35 (17,2%) | 204 |